Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Smit

Showing results (271-280 of 692) with videos related to

Pageof 70
Sort By:
Therapeutic Drug Monitoring|June 22, 2023
Clinical Relevance of High Plasma Trough Levels of the Kinase Inhibitors Crizotinib, Alectinib, Osimertinib, Dabrafenib, and Trametinib in NSCLC PatientsLishi Lin, Hannerieke J Barkman, Egbert F Smit, et al.
Case Reports in Oncology|April 8, 2014
Benefit of a second opinion for lung cancer: no metastasis to the kidney but a synchronous primary renal neoplasmMarleen J Ter Avest, Romane M Schook, Lyan G Koudstaal, et al.
Chest|October 21, 2005
Clinical prediction model to characterize pulmonary nodules: validation and added value of 18F-fluorodeoxyglucose positron emission tomographyGerarda J Herder, Harm van Tinteren, Richard P Golding, et al.
Archives of Otolaryngology--Head & Neck Surgery|July 11, 2000
Gastropharyngeal and gastroesophageal reflux in globus and hoarsenessC F Smit, J A van Leeuwen, L M Mathus-Vliegen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 4, 2001
Dose-finding and pharmacological study of ifosfamide in combination with paclitaxel and carboplatin in resistant small-cell lung cancerJ W van Putten, T Kerbush, E F Smit, et al.
Immunity|September 25, 2001
Comparative genomics of the human and mouse T cell receptor lociG Glusman, L Rowen, I Lee, et al.
The Oncologist|November 4, 2020
Navigating Diagnostic and Treatment Decisions in Non-Small Cell Lung Cancer: Expert Commentary on the Multidisciplinary Team ApproachSanjay Popat, Neal Navani, Keith M Kerr, et al.
Respiratory Medicine Case Reports|June 2, 2015
Benefit of a second opinion: From metastatic disease to resectable lung cancer with sarcoid-like reactionRomane M Schook, Lyan Koudstaal, Emile F Comans, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 5, 2012
Tumor cavitation in patients with stage III non-small-cell lung cancer undergoing concurrent chemoradiotherapy: incidence and outcomesErik C J Phernambucq, Koen J Hartemink, Egbert F Smit, et al.
Cancers|November 13, 2020
Epithelial Transfer of the Tyrosine Kinase Inhibitors Erlotinib, Gefitinib, Afatinib, Crizotinib, Sorafenib, Sunitinib, and Dasatinib: Implications for Clinical ResistanceRichard J Honeywell, Ietje Kathmann, Elisa Giovannetti, et al.
Pageof 70

Showing results (271-280 of 692) with videos related to

Sort By:
Pageof 70
Therapeutic Drug Monitoring|June 22, 2023
Clinical Relevance of High Plasma Trough Levels of the Kinase Inhibitors Crizotinib, Alectinib, Osimertinib, Dabrafenib, and Trametinib in NSCLC PatientsLishi Lin, Hannerieke J Barkman, Egbert F Smit, et al.
Case Reports in Oncology|April 8, 2014
Benefit of a second opinion for lung cancer: no metastasis to the kidney but a synchronous primary renal neoplasmMarleen J Ter Avest, Romane M Schook, Lyan G Koudstaal, et al.
Chest|October 21, 2005
Clinical prediction model to characterize pulmonary nodules: validation and added value of 18F-fluorodeoxyglucose positron emission tomographyGerarda J Herder, Harm van Tinteren, Richard P Golding, et al.
Archives of Otolaryngology--Head & Neck Surgery|July 11, 2000
Gastropharyngeal and gastroesophageal reflux in globus and hoarsenessC F Smit, J A van Leeuwen, L M Mathus-Vliegen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 4, 2001
Dose-finding and pharmacological study of ifosfamide in combination with paclitaxel and carboplatin in resistant small-cell lung cancerJ W van Putten, T Kerbush, E F Smit, et al.
Immunity|September 25, 2001
Comparative genomics of the human and mouse T cell receptor lociG Glusman, L Rowen, I Lee, et al.
The Oncologist|November 4, 2020
Navigating Diagnostic and Treatment Decisions in Non-Small Cell Lung Cancer: Expert Commentary on the Multidisciplinary Team ApproachSanjay Popat, Neal Navani, Keith M Kerr, et al.
Respiratory Medicine Case Reports|June 2, 2015
Benefit of a second opinion: From metastatic disease to resectable lung cancer with sarcoid-like reactionRomane M Schook, Lyan Koudstaal, Emile F Comans, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 5, 2012
Tumor cavitation in patients with stage III non-small-cell lung cancer undergoing concurrent chemoradiotherapy: incidence and outcomesErik C J Phernambucq, Koen J Hartemink, Egbert F Smit, et al.
Cancers|November 13, 2020
Epithelial Transfer of the Tyrosine Kinase Inhibitors Erlotinib, Gefitinib, Afatinib, Crizotinib, Sorafenib, Sunitinib, and Dasatinib: Implications for Clinical ResistanceRichard J Honeywell, Ietje Kathmann, Elisa Giovannetti, et al.
Pageof 70